Skip to main content
Elsevier - PMC Mpox Collection logoLink to Elsevier - PMC Mpox Collection
letter
. 2022 Sep 27;50:102466. doi: 10.1016/j.tmaid.2022.102466

Unusual epidemiological presentation of the first reports of monkeypox in a low-income region of Brazil

Paulo Ricardo Martins-Filho 1,, Mércia Feitosa de Souza 2, Marco Aurélio Oliveira Góis 3,4, Gabriela Vasconcelos Brito Bezerra 5, Cassia Cristina Alves Gonçalves 6, Érica Ramos dos Santos Nascimento 6, Cinthia Francisca Valdez 6, Amilcar Tanuri 6, Clarissa R Damaso 7, Cliomar Alves dos Santos 8
PMCID: PMC9534079  PMID: 36180021

Monkeypox virus is a zoonotic, double-stranded DNA virus, member of the Orthopoxvirus genus, that occurs primarily in tropical areas of central and west Africa. However, since May 2022, the number of monkeypox cases has increased dramatically worldwide. As of September 14, more than 60,000 cases of the disease had been reported, with Brazil accounting for approximately 10% (https://ourworldindata.org/monkeypox). The first case of monkeypox in Brazil was diagnosed on June 7, 2022, in the state of São Paulo, in a 41-year-old male patient with a recent travel history to Portugal and Spain [1]. Here, we describe the first three cases of monkeypox in Sergipe state, Northeast Brazil, recognized as one of the poorest regions of the country. According to the Brazilian Institute of Geography and Statistics (IBGE, acronym in Portuguese), the state has an estimated population of approximately 2.3 million inhabitants, a Human Development Index of 0.665, and the proportion of illiterates and those living on half the minimum wage per month is 13.5% and approximately 50%, respectively.

All cases were diagnosed between August 22 and August 26, 2022. Samples were obtained from skin lesions and were all positive for monkeypox DNA using real-time polymerase chain reaction (RT-PCR). Dry swabs were incubated in 400 μl of PBS at 37 °C for 30 minutes, with vigorous vortexing every 10 minutes. Total DNA was extracted from the resulting supernatant using a KingFisher Flex System® (Thermofisher, USA) and the MagMax Viral/Pathogen Nucleic Acid Isolation Kit (Thermofisher, USA), according to manufacturer's instructions. Monkeypox DNA was detected using a triplex real-time PCR assay (7500 Thermal Cycler, Applied Biosystems, USA) for Orthopoxvirus targeting the F4L gene, general monkeypox targeting the J2R gene, and the human RNase P gene as endogenous control. Positive samples had cycle threshold (Ct) values less than 37.

The first case involved a 28-year-old woman who sought medical attention 15 days after the onset of systemic symptoms (fever, asthenia, headache, and sore throat) for evaluation of multiple pruritic, papulovesicular lesions on the limbs, trunk, and oral mucosa. The second case was a 12-year-old girl who presented with fever and headache, as well as multiple well-circumscribed pruritic, pustular lesions on the arms, trunk, and face with central umbilication. None of the patients reported any known contact with a confirmed case, people experiencing similar symptoms, or recent travel abroad. The patients were in good clinical condition and did not require hospitalization.

The third case involved a 24-year-old bisexual man who presented to an ambulatory clinic 6 days after the onset of systemic symptoms for evaluation of multiple well-circumscribed pustular lesions on the arms and perianal area with central umbilication. There were no lesions in the oral cavity or genital region. The patient had inguinal lymphadenopathy. Despite his denial of close contact with a confirmed case or travel abroad, the patient reported sexual exposure 10 days before onset of symptoms. Serology tests for HIV and other sexually transmitted infections (STIs) (syphilis and herpes simplex virus) were negative. The patient was in good clinical condition and did not require hospitalization. The clinical and epidemiological characteristics of the patients are detailed in Table 1 .

Table 1.

Clinical and epidemiological characteristics of the first monkeypox cases in the state of Sergipe, Northeast Brazil.

Variables Case 1 Case 2 Case 3
Sex Female Female Male
Sexual orientation Heterosexual Heterosexual Bisexual
Age 28 years 12 years 24 years
Days between onset of symptoms and onset of lesions 15 1 2
Diagnosis
 Method RT-PCR RT-PCR RT-PCR
 Sample Skin swab Skin swab Skin swab
 Days between the onset of lesions and sampling 1 4 4
 Ct values 31 36 16
Systemic symptoms
 Lymphadenopathy No No Yes
 Inguinal No No Yes
 Cervical No No No
 Axillary No No No
 Fever Yes Yes Yes
 Asthenia Yes Yes Yes
 Headache Yes No Yes
 Myalgia No No Yes
 Sore throat Yes No Yes
Mucocutaneous lesions Yes Yes Yes
Location
 Hands/feet No No No
 Arms/legs Yes Yes Yes
 Trunk Yes Yes No
 Face No Yes No
 Genital No No No
 Anal/perianal No No Yes
 Oropharynx/oral mucosa/lips Yes No No
Hospitalization No No No
Prior vaccination against smallpox No No No
Known contact with a confirmed case No No No
Travel abroad No No No
Sexual exposure within the 21 days before onset of symptoms No No Yes
Concomitant sexually transmitted infection
 Syphilis and herpes simplex virus infection No No No
 HIV No No No

Ct, cycle threshold.

Epidemiological studies [2] have shown that most cases of the 2022 monkeypox outbreak have occurred predominantly among men who have sex with (MSM) in their fourth and fifth decades of life, with a high prevalence of lesions in the anogenital region and oral mucosa, suggesting that close skin-to-skin or skin-to-mouth contact during unprotected sexual intercourse is the primary route of monkeypox transmission [3]. In addition to the majority of cases in the current outbreak being associated with high-risk MSM sexual behavior, a high prevalence of HIV and other STIs has been reported among these individuals [4].

Our findings are important because they show an unusual epidemiological presentation of the first reports of monkeypox in the region than has been reported elsewhere. Although one of the three cases was registered in an MSM and the lesions were found in the expected locations, such as the perianal region, the other two cases were recorded in female patients with an unknown transmission route. In particular, one case was diagnosed in a 12-year-old girl without anogenital involvement. Despite most monkeypox cases in endemic areas of Central and West Africa are diagnosed among children and adolescents [5], the prevalence of disease in the pediatric population during the current multi-country outbreak is less than 0.3% [6,7]. Professionals caring for children and adolescents should not base their assessments solely on epidemiological risk factors or exposure to confirmed monkeypox patients. Careful monitoring of upcoming monkeypox cases in the region is required to track the virus spread to the general population. Low-income areas are particularly concerning because poor people have less consistent access to primary care, which can exacerbate virus spread in underserved communities.

Authors contributions

All authors contributed equally to this manuscript.

Financial source

CD thanks CNPq and FAPERJ for research fellowships. These sponsors had no role in the study design, execution, analysis, interpretation of data, or decision to present the results.

Declaration of competing interest

The authors declare they have no conflicts of interest.

References

  • 1.Claro I.M., Romano C.M., da Candido D.S., de Lima E.L., Lindoso J.A.L., Ramundo M.S., et al. Rev Inst Med Trop Sao Paulo; 2022. Shotgun metagenomic sequencing of the first case of monkeypox virus in Brazil, 2022. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Iñigo Martínez J., Gil Montalbán E., Jiménez Bueno S., Martín Martínez F., Nieto Juliá A., Sánchez Díaz J., et al. Monkeypox outbreak predominantly affecting men who have sex with men, Madrid, Spain, 26 April to 16 June 2022. Euro Surveill. 2022;27 doi: 10.2807/1560-7917.ES.2022.27.27.2200471. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Martins-Filho P.R., Tanajura D.M., Alves dos Santos C. Polymerase chain reaction positivity and cycle threshold values in biological samples from patients with monkeypox: a meta-analysis. Trav Med Infect Dis. 2022;50 doi: 10.1016/j.tmaid.2022.102448. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Tarín-Vicente E.J., Alemany A., Agud-Dios M., Ubals M., Suñer C., Antón A., et al. Clinical presentation and virological assessment of confirmed human monkeypox virus cases in Spain: a prospective observational cohort study. Lancet. 2022 doi: 10.1016/S0140-6736(22)01436-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Beer E.M., Rao V.B. A systematic review of the epidemiology of human monkeypox outbreaks and implications for outbreak strategy. PLoS Neglected Trop Dis. 2019;13 doi: 10.1371/journal.pntd.0007791. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Aguilera-Alonso D., Alonso-Cadenas J.A., Roguera-Sopena M., Lorusso N., Miguel L.G.S., Calvo C. Monkeypox virus infections in children in Spain during the first months of the 2022 outbreak. Lancet Child Adolesc Heal. 2022 doi: 10.1016/S2352-4642(22)00250-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Cohen J., Ladhani S.N. Monkeypox and children. Arch Dis Child. 2022 doi: 10.1136/archdischild-2022-324703. archdischild-2022-324703. [DOI] [PubMed] [Google Scholar]

Articles from Travel Medicine and Infectious Disease are provided here courtesy of Elsevier

RESOURCES